MM

Mark Mandel

Board Member at Trefoil Therapeutics

No bio yet


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Trefoil Therapeutics

Trefoil is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop first-in-class regenerative pharmacologic treatments for corneal diseases, which are debilitating and cause a significant amount of preventable blindness throughout the world.